Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Vivani Medical, Inc.NASDAQ: VANI
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 51.8% from a year ago
Cash & equivalents stood at $19.75M at the end of Q1 FY2026, up 51.8% from a year earlier and up 21.7% from the prior quarter. Over 3 fiscal years it compounded at -28.9% a year.
Context
- Cash & equivalents amounted to 46.6% of total assets at the end of Q1 FY2026, up 9.9 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +51.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 16.23M USD
- Year-over-year change
- -11.6%
- 4-year CAGR
- +65.2%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.23M | -11.6% |
| FY2024 | 2024-12-31 | 18.35M | -11.1% |
| FY2023 | 2023-12-31 | 20.65M | -54.2% |
| FY2022 | 2022-12-31 | 45.08M | +1969.6% |
| FY2021 | 2021-12-31 | 2.18M | — |
Cash & Equivalents vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +51.8% is the 2nd highest of 8, against a peer median of +13.7%.
- Cash & equivalents amounts to 46.6% of total assets for VANI, versus a peer median of 24.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IMAImageneBio Inc | Mar 2026 | $76.05M USD | +106.9% | -16.4% | 55.6% |
| Mar 2026 | $53.65M USD | -1.1% | +5.0% | 24.5% | |
| Mar 2026 | $40.78M USD | +23.2% | -33.3% | 67.6% | |
| Mar 2026 | CA$27.74M CAD | +19.1% | -21.2% | 88.1% | |
| Mar 2026 | $19.75M USD | +51.8% | -28.9% | 46.6% | |
| Mar 2026 | $13.2M USD | -82.3% | +4.3% | 4.9% | |
| Mar 2026 | $8.31M USD | -44.1% | -17.4% | 16.1% | |
| Mar 2026 | $3.66M USD | +13.7% | +15.8% | 4.7% | |
| Peer median (excluding VANI) | — | +13.7% | -16.4% | 24.5% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.